Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05704699
Other study ID # 122046
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date December 31, 2023

Study information

Verified date January 2023
Source Western University, Canada
Contact Peter Lemon, PhD
Phone 519-661-2111
Email plemon@uwo.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To our knowledge, as of this day there are only four studies which examined the effects of eTRE with a duration of 12 weeks. There are no studies that examined this phenomenon beyond 12 weeks, one study that lasted five weeks and four studies that lasted 4 weeks or less, some even days. The four studies that lasted 12 weeks in duration all have opportunities to improve upon, which will be discussed here. The first study performed by Gabel et al., focused primarily on measuring body weight, not body composition in older adults. The eating window also began later in the morning at 1000h and finished at 1800h. There also was no restriction on participants consuming caffeine during the fasting window. The second study conducted by Gasmi et al., was focused on strictly older male participants that were active and healthy, again, without measuring body composition. The third study conducted by Wilkinson et al., did not measure body composition and the eating window lasted 10 hours instead of 8. The fourth study performed by Chow et al., examined eTRE with adults aged 45+/-12 years old and did not mention any exclusion criteria based upon physical activity levels or restrictions on caffeine/artificial sweetener intake during the fasting window. Furthermore, none of the studies mentioned above examined eTRE against eTRE with Brief Intense Stair Climbing (BISC) directly. We believe that the proposed study will address the concerns mentioned previously and further knowledge associated with eTRE.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - sedentary- lightly physically active (<7,500 steps daily) - BMI > 25 • 18-39 years old Exclusion Criteria: - Have diabetes (self-reported) - Have history of smoking (self-reported) - Have history of cardiovascular disease (self-reported) - Have BMI of <24.9 - Are pregnant or become pregnant during the study (self-reported) - Take medication for weight loss (self-reported) - Physical activity level > 7500 steps/day - Unstable weight for 3 months prior to commencement of study (>4kg weight loss/gain) • Employed in a shift work position

Study Design


Related Conditions & MeSH terms

  • eTRE (Early Time Restricted Eating)

Intervention

Behavioral:
eTRE
eating between 0800h and 1600h daily
eTRE with BISC
eating between 0800h and 1600h daily and completing 3 sessions of BISC per week of study duration

Locations

Country Name City State
Canada Exercise Nutrition Laboratory, Western University London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Western University, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Composition fat mass vs. fat-free mass via BodPod less than 5 mins
Secondary upper body strength test 3-rep max bench press < 15 mins
Secondary lower body strength test 3-rep max leg press < 15 mins
Secondary health related quality of life questionnaire subjective feelings of well-being per participant < 10 mins
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05589142 - Effect of Early Eating and BCAA Supplementation on Body Composition N/A
Not yet recruiting NCT04679155 - Effect of Early Eating on Body Composition N/A